Introduction:
The pharmaceutical industry in Ireland has been experiencing steady growth over the past few years, with the country becoming a hub for biopharmaceutical companies. In 2026, Ireland is set to host some of the top players in the biopharmaceutical sector, contributing significantly to the country’s economy. According to industry reports, the biopharmaceutical market in Ireland is expected to reach a value of $10 billion by 2026.
Top 10 Biopharmaceutical Companies in Ireland 2026:
1. Pfizer Ireland Pharmaceuticals
– Market share: 15%
– Pfizer Ireland Pharmaceuticals is a leading player in the Irish biopharmaceutical industry, known for its innovative products and cutting-edge research in areas such as oncology and rare diseases.
2. Eli Lilly and Company
– Market share: 12%
– Eli Lilly and Company is a key player in the Irish biopharmaceutical market, focusing on developing treatments for diabetes, oncology, and neurodegenerative diseases.
3. AbbVie Ireland
– Market share: 10%
– AbbVie Ireland is a major biopharmaceutical company in Ireland, known for its strong portfolio of products in immunology, oncology, and virology.
4. Amgen Ireland
– Market share: 8%
– Amgen Ireland is a significant player in the Irish biopharmaceutical sector, specializing in biotechnology-based therapies for cancer and inflammatory diseases.
5. Merck Sharp & Dohme (Ireland) Limited
– Market share: 7%
– Merck Sharp & Dohme (Ireland) Limited is a key contributor to the Irish biopharmaceutical industry, with a focus on innovative medicines for various therapeutic areas.
6. Bristol Myers Squibb
– Market share: 6%
– Bristol Myers Squibb is a prominent biopharmaceutical company in Ireland, known for its research and development efforts in oncology, hematology, and immunology.
7. Takeda Pharmaceuticals Ireland
– Market share: 5%
– Takeda Pharmaceuticals Ireland is a significant player in the Irish biopharmaceutical market, specializing in therapies for rare diseases, gastroenterology, and oncology.
8. Novartis Ireland Limited
– Market share: 4%
– Novartis Ireland Limited is a leading biopharmaceutical company in Ireland, focusing on innovative treatments for cardiovascular diseases, respiratory conditions, and ophthalmology.
9. Roche Ireland Limited
– Market share: 3%
– Roche Ireland Limited is a key player in the Irish biopharmaceutical sector, known for its expertise in oncology, immunology, and infectious diseases.
10. Johnson & Johnson
– Market share: 2%
– Johnson & Johnson is a significant contributor to the Irish biopharmaceutical industry, with a focus on pharmaceuticals, medical devices, and consumer health products.
Insights:
The biopharmaceutical industry in Ireland is poised for continued growth in the coming years, driven by factors such as increasing investment in research and development, a skilled workforce, and a favorable regulatory environment. With the top 10 biopharmaceutical companies in Ireland leading the way, the country is set to solidify its position as a key player in the global pharmaceutical market. By 2026, the biopharmaceutical market in Ireland is projected to grow by 10%, reaching a value of $10 billion. This growth presents significant opportunities for both domestic and international players looking to establish a presence in Ireland’s thriving biopharmaceutical sector.
Related Analysis: View Previous Industry Report
